Stefan Dirnhofer
Overview
Explore the profile of Stefan Dirnhofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimby Professor Emerita E, Schar S, Pirosa M, Vanazzi A, Mey U, Rauch D, et al.
Blood Adv
. 2025 Jan;
PMID: 39883948
The Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG) conducted the SAKK 35/10 randomized phase-2 trial (NCT0137605) to compare rituximab (R) alone versus R plus...
2.
Ivanova V, Menter T, Cui N, Leary P, Zinner C, Halter J, et al.
Br J Haematol
. 2025 Jan;
206(2):484-504.
PMID: 39777628
Post-transplant lymphoproliferative disorders (PTLD) and lymphomas in immunocompromised individuals represent significant clinical challenges, with a limited understanding of their pathogenesis. We investigated a PTLD cohort (n = 50) consisting of...
3.
Mendeville M, Janssen J, Los-de Vries G, van Dijk E, Richter J, Nijland M, et al.
Nat Commun
. 2025 Jan;
16(1):109.
PMID: 39747123
Next Generation Sequencing-based subtyping and interim- and end of treatment positron emission tomography (i/eot-PET) monitoring have high potential for upfront and on-treatment risk assessment of diffuse large B-cell lymphoma patients....
4.
Bonometti A, Tzankov A, Alborelli I, Went P, Dirnhofer S
Leuk Lymphoma
. 2025 Jan;
66(1):139-146.
PMID: 39745903
No abstract available.
5.
Bonaiti E, Muraro M, Robert P, Jakscha J, Dirnhofer S, Martin I, et al.
Front Immunol
. 2024 Oct;
15:1425455.
PMID: 39355250
Introduction: Vaccination is one of the most effective infection prevention strategies. Viruses with high mutation rates -such as influenza- escape vaccine-induced immunity and represent significant challenges to vaccine design. Influenza...
6.
Brand M, Tzankov A, Scheijde-Vermeulen M, Barbe E, Dirnhofer S, Stenner F, et al.
Leuk Lymphoma
. 2024 Aug;
65(14):2211-2214.
PMID: 39205632
No abstract available.
7.
Bonometti A, Tzankov A, Alborelli I, Russkamp N, Dertinger S, Dirnhofer S
Virchows Arch
. 2024 Aug;
PMID: 39107523
Intrasinusoidal bone marrow involvement is an infrequent histological pattern observed in a limited number of B and T cell lymphomas. Mantle cell lymphoma is a biologically and prognostically heterogeneous B...
8.
Campo E, Dierickx D, Dirnhofer S, Dunleavy K, Gaulard P, Hasserjian R, et al.
J Clin Oncol
. 2024 Jul;
42(27):3177-3182.
PMID: 39018505
No abstract available.
9.
Schmidt-Barbo P, Kalweit G, Naouar M, Paschold L, Willscher E, Schultheiss C, et al.
PLoS Comput Biol
. 2024 Jul;
20(7):e1011570.
PMID: 38954728
The classification of B cell lymphomas-mainly based on light microscopy evaluation by a pathologist-requires many years of training. Since the B cell receptor (BCR) of the lymphoma clonotype and the...
10.
Ivanova V, Menter T, Zaino J, Mertz K, Hamelin B, Dirnhofer S, et al.
Am J Surg Pathol
. 2024 Jun;
48(10):1259-1269.
PMID: 38864239
Extranodal marginal zone lymphomas (eMZL) can occur in any organ and site of the body. Recent research has shown that they differ from organ to organ in terms of their...